Utah-based Huntsman Cancer Institute helps in development, testing of breakthrough drug for pancreatic cancer

The FDA approved a new drug that nearly doubles median overall survival for advanced pancreatic cancer patients, developed and tested with help from Utah's Huntsman Cancer Institute. A Huntsman oncologist discusses the breakthrough on Inside Sources.

Read the full story at play.cdnstream1.com

This is a summary with a link to the original. The reporting belongs to KSL's Inside Sources.